HOME >> BIOLOGY >> NEWS
Heart intervention doesn't outweigh medicine in study

stable, symptoms and reasonable heart strength, the COURAGE trial shows that an initial strategy of aggressive medical treatment is equally as effective as angioplasty and stenting in the prevention of fatal and nonfatal heart attack and hospitalization," Booth said.

While the findings are expected to significantly impact patient care practices in some settings, as noted in an accompanying editorial in NEJM, the study supports the approach to patient care at the University of Kentucky, notes Dr. David Moliterno, UK College of Medicine chief of cardiovascular medicine and co-director of the UK Gill Heart Institute. "UK has been carefully and cautiously approaching patients in the treatment of heart disease as we endeavor to provide the best medical care available," Moliterno said. "Because of our position of prudence and patient care first, we were among the top enrolling centers in this study and a co-author of the findings."


'"/>

Contact: Beth Goins
beth.goins@uky.edu
859-327-0078
University of Kentucky
27-Mar-2007


Page: 1 2

Related biology news :

1. Hearts of male and female rainbow trout are different
2. Heart failure: Intervention possibilities from imaging programmed cell loss
3. International Society for Heart and Lung Transplantation 27th Annual Meeting and Scientific Sessions
4. Heart rhythm genes possible factors in SIDS
5. Hearts or tails?
6. Heart smart: new drug improves blood flow
7. Heart has enough oxygen to survive hypothermia, CPR crucial
8. Defusing a time bomb: Heart attack risk-detection technology developed at UH
9. Heart failure wall stress drops 38% with moderate thyroid hormone therapy
10. New studies released at the Heart Rhythm Societys Annual Meeting
11. Molecular testing impact: Heart transplant patients benefit from new technology, easier monitoring

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... (PRWEB) , ... August 12, 2020 , ... ... and monitoring systems that are ideal for public health agencies of all sizes. ... contagious diseases and helping at-risk individuals find appropriate health care, Mosio helps public ...
(Date:8/5/2020)... ... ... Regenative Labs has received approval from the Centers for Medicare & Medicaid ... Wharton’s jelly allografts to be assigned a Q code and be approved for application ... jelly allograft product to be recognized as a 361 HCT/P by CMS regulated under ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to lead upcoming ... term focus on Type 2 diabetes and associated comorbidities. , Justin brings over ... and classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 29, 2020 , ... ... growth of 40% in 2020, despite many obstacles created as a result of ... increase revenue for its partnered medical practices and medical manufacturers by expanding access ...
(Date:7/1/2020)... WESTMINSTER, Colo. (PRWEB) , ... ... ... providers of expert tissue data insights, today announced that the launch of ... PD-L1 results along with data about the tumor microenvironment (TME). , “Flagship’s ...
(Date:6/28/2020)... JOSE, Calif. (PRWEB) , ... June 25, 2020 ... ... globe, researchers are racing to develop a vaccine or drug treatment. In an ... Recursion has publicly released the world’s largest imaging dataset portraying therapeutic ...
(Date:6/28/2020)... Md. (PRWEB) , ... June 26, 2020 , ... ... trade association representing security solutions providers, today announced its strong opposition to the ... The bill would impose a blanket ban on most federal use of nearly ...
Breaking Biology Technology:
Cached News: